Effects of Intranasal Nerve Growth Factor for Acute Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.
Also called NCT03686163
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 106 participants
- Sponsor
- Registry
-
NCT03686163
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03686163. Randomized; single masking; primary purpose treatment. Start 2016-01 (actual); primary completion 2019-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Intranasal Nerve Growth Factor for Acute Ischemic Stroke
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Nerve Growth Factors
- Intervention (Drug)
- normal saline
- Lead sponsor
- Jinling Hospital, China
Record details
- Record id
cardio:ct-nct03686163- Content hash
8e8714642c579c6326acefa2b2859d6a6c94a9b2553cdf500d22cca4e3af8a3b